Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
RIGL Rigel Pharmaceuticals
- 17.090
- -0.120-0.70%
Close Dec 20 16:00 ET
- 17.090
- 0.0000.00%
Post 16:20 ET
301.04MMarket Cap63.30P/E (TTM)
17.760High16.850Low413.26KVolume16.850Open17.210Pre Close7.08MTurnover2.77%Turnover RatioLossP/E (Static)17.62MShares29.82052wk High-20.57P/B255.37MFloat Cap7.48452wk Low--Dividend TTM14.94MShs Float1147.499Historical High--Div YieldTTM5.29%Amplitude6.400Historical Low17.120Avg Price1Lot Size
About Rigel Pharmaceuticals Company
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.
Company Profile
SymbolRIGL
Company NameRigel Pharmaceuticals
Listing DateNov 29, 2000
Issue Price7.00
Founded1996
CEOMr. Raul R. Rodriguez
MarketNASDAQ
Employees147
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1985
Phone1-650-624-1100
Websitehttp://www.rigel.com
Company Executives
- Name
- Position
- Salary
- Raul R. Rodriguez
- Director, President and Chief Executive Officer
- 3.44M
- Dean L. Schorno
- Executive Vice President and Chief Financial Officer
- 1.21M
- David A. Santos
- Executive Vice President and Chief Commercial Officer
- 1.34M
- Raymond J. Furey
- Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
- 683.00K
- Gregg Anthony Lapointe, C.P.A.,M.B.A.
- Chairman of the Board
- 190.58K
- Jane Wasman, J.D.
- Independent Director
- 145.58K
- Dr. Alison L. Hannah, M.D.
- Independent Director
- 212.98K
- Dr. Walter H. Moos,PhD
- Independent Director
- 138.58K
- Kamil Ali-Jackson, Esq.
- Independent Director
- 140.58K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.